3,000 of them from the UK. The results will be released today at a conference in Florida of the American Society of Clinical Oncology. Arimidex was also found to be more likely to prevent cancer ...

The UK pharma has already sold rights to both Arimidex and Casodex in the US in 2017. There were no closing conditions to the divestment and the agreement became effective on signing.

pharmaphorum speaks with Steven Davis of AstraZeneca on how the first year of its first direct-to-patient program - ARIMIDEX Direct has been. A year ago, AstraZeneca announced its first direct-to ...